RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 55 filers reported holding RAPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,244,447 | +55.9% | 135,045 | +75.4% | 0.02% | +41.7% |
| Q2 2023 | $1,439,824 | -74.2% | 76,996 | -72.7% | 0.01% | -73.9% |
| Q4 2022 | $5,581,125 | +118.2% | 281,875 | +165.2% | 0.05% | +119.0% |
| Q3 2022 | $2,558,000 | -3.2% | 106,290 | -26.6% | 0.02% | -19.2% |
| Q2 2022 | $2,643,000 | +19.0% | 144,836 | +43.4% | 0.03% | +30.0% |
| Q1 2022 | $2,221,000 | -74.1% | 101,000 | -56.7% | 0.02% | -74.0% |
| Q4 2021 | $8,565,000 | +40.4% | 233,177 | +18.7% | 0.08% | +22.2% |
| Q3 2021 | $6,099,000 | -1.1% | 196,434 | +1.3% | 0.06% | -4.5% |
| Q2 2021 | $6,164,000 | +294.9% | 193,930 | +175.8% | 0.07% | +247.4% |
| Q1 2021 | $1,561,000 | -33.3% | 70,325 | -40.6% | 0.02% | -38.7% |
| Q4 2020 | $2,340,000 | -70.9% | 118,467 | -52.5% | 0.03% | -79.7% |
| Q3 2020 | $8,036,000 | +144.0% | 249,531 | +119.9% | 0.15% | +247.7% |
| Q2 2020 | $3,294,000 | – | 113,484 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |